Nanoformulation of paclitaxel to enhance cancer therapy

Journal of Biomaterials Applications

Volumn 28, Issue 2, 2013, Pages 298-307

  Gu, Quanrong ^a,b   Xing, James Z ^a,c   Huang, Min ^a   Zhang, Xiaojing ^d   Chen, Jie ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

^c CROSS CANCER INSTITUTE   (Canada)

^d Department of Surgical Oncology   (China)

Author keywords

cancer chemotherapy; drug delivery; nanoformulation; Paclitaxel; pluronic copolymer; water soluble

Indexed keywords

CANCER CHEMOTHERAPY; NANOFORMULATION; PACLITAXEL; PLURONIC COPOLYMERS; WATER-SOLUBLE;

CHEMOTHERAPY; COPOLYMERS; DISEASES; DRUG DELIVERY; ENZYME INHIBITION; LOADING; NANOPARTICLES; SYNTHESIS (CHEMICAL); TOXICITY;

HYDROGELS;

NANOCARRIER; PACLITAXEL; PHOSPHATE BUFFERED SALINE; POLOXAMER; SORBITAN PALMITATE;

ANTINEOPLASTIC ACTIVITY; AQUEOUS SOLUTION; ARTICLE; CANCER CELL CULTURE; CANCER THERAPY; CELL KILLING; CELL STRAIN MCF 7; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG UPTAKE; HELA CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; IN VITRO STUDY; NANOENCAPSULATION; NANOPHARMACEUTICS; NANOTOXICOLOGY; PARTICLE SIZE; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; SCANNING ELECTRON MICROSCOPY; TOXICITY TESTING; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84881125656     PISSN: 08853282     EISSN: 15308022     Source Type: Journal    
DOI: 10.1177/0885328212446822     Document Type: Article

References (30)

1. Elaine M, Gary G. Drug nanoparticles: formulating poorly water-soluble compounds. Toxicol Pathol. 2008 ; 36: 43-48
2. Alexis F, Rhee JW, Richie JP, et al. New frontiers in nanotechnology for cancer treatment. Urol Oncol: Seminars and Original Investigations. 2008 ; 26: 74-85
3. Strieth S, Eichhorn ME, Werner A, et al. Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin. Clin Cancer Res. 2008 ; 14: 4603-4611
4. Crosasso P, Ceruti M, Brusa P, et al. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release. 2000 ; 63: 19-30
5. Kan P, Tsao CW, Wang AJ, et al. A liposomal formulation able to incorporate a high content of paclitaxel and exert promising anticancer effect. J Drug Deliv. 2011 ; 2011: 1-9
6. Wang T, Petrenko VA, Torchilin VP. Paclitaxel-loaded polymeric micelles modified with MCF-7 cell-specific phage protein: enhanced binding to target cancer cells and increased cytotoxicity. Mol Pharm. 2010 ; 7(4): 1007-1014
7. Tong R, Yala L, Fan TM, et al. The formulation of aptamer-coated paclitaxel-polylactide nanoconjugates and their targeting to cancer cells. Biomaterials. 2010 ; 31: 3043-3053
8. Zhu ZS, Li Y, Li XL, et al. Paclitaxel-loaded poly(N-vinylpyrrolidone)-b- poly(epsilon-caprolactone) nanoparticles: preparation and antitumor activity in vivo. J Control Release. 2010 ; 142: 438-446
9. Burt HM, Zhang XC, Toleikis P, et al. Development of copolymers of poly(d,l-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel. Colloids Surf B: Biointerfaces. 1999 ; 16: 161-171
10. Cavalli R, Caputo O, Gasco MR. Preparation and characterization of solid lipid nanospheres containing paclitaxel. Eur J Pharm Sci. 2000 ; 10: 305-309
11. Lee H, Jeong YH, Park TG. Oil-encapsulating PEO-PPO-PEO/PEG shell cross-linked nanocapsules for target-specific delivery of paclitaxel. Biomacromolecules. 2007 ; 8: 650-656
12. Lacoeuille F, Hindre F, Moalc F, et al. In vivo evaluation of lipid nanocapsules as a promising colloidal carrier for paclitaxel. Int J Pharm. 2007 ; 344: 143-149
13. Bilensoy E, Gurkaynak O, Dogan AL, et al. Safety and efficacy of amphiphilic ß-cyclodextrin nanoparticles for paclitaxel delivery. Int J Pharm. 2008 ; 347: 163-170
14. Gelderblom H, Verweij J, Zomeren DM, et al. Influence of cremophor El on the bioavailability of intraperitoneal paclitaxel. Clin Cancer Res. 2002 ; 8: 1237-1241
15. Torchilin VP. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci. 2004 ; 61: 2549-2559
16. Manakker F, Vermonden T, Nostrum CF, et al. Cyclodextrin-based polymeric materials: synthesis, properties, and pharmaceutical/biomedical applications. Biomacromolecules. 2009 ; 10: 3157-3175
17. Huynh NT, Passirani C, Saulnier P, et al. Lipid nanocapsules: a new platform for nanomedicine. Int J Pharm. 2009 ; 379: 201-209
18. Blanco E, Kessinger CW, Sumer BD, et al. Multifunctional micellar nanomedicine for cancer therapy. Exp Biol Med (Maywood). 2009 ; 234(2): 123-131
19. Sutton D, Nasongkla N, Blanco E, et al. Functionalized micellar systems for cancer targeted drug delivery. Pharm Res. 2007 ; 24(6): 1029-1046
20. Moës AJ, Amighi K, Eeckman F. Poly(N-isopropylacrylamide) copolymers for constant temperature controlled drug delivery. Int J Pharm. 2004 ; 273: 109-119
21. Wang YZ, Li YJ, Han LM, et al. Difunctional pluronic copolymer micelles for paclitaxel delivery: synergistic effect of folate-mediated targeting and pluronic-mediated overcoming multidrug resistance in tumor cell lines. Int J Pharm. 2007 ; 337: 63-73
22. Zhang W, Shi Y, Chen Y, et al. Multifunctional pluronic P123/F127 mixed polymeric micelles loaded with paclitaxel for the treatment of multidrug resistant tumors. Biomaterials. 2011 ; 32: 2894-2906
23. Schiff PB, Horwitz SB. Promotion of microtubule assembly in vitro by taxol. Nature. 1979 ; 277: 665-667
24. Lin YS, Tungpradit R, Sinchaikul S, et al. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters. J Med Chem. 2008 ; 51: 7428-7441
25. Mathew AE, Mejillano MR, Nath JP, et al. Synthesis and evaluation of some water-soluble prodrugs and derivatives of taxol with antitumor activity. J Med Chem. 1992 ; 35: 145-151
26. Zhang W, Hao J, Shi Y, et al. Paclitaxel-loaded pluronic P123/F127 mixed polymeric micelles: formulation, optimization and in vitro characterization. Int J Pharm. 2009 ; 376: 176-185
27. Oh KS, Song JY, Cho SH, et al. Paclitaxel-loaded pluronic nanoparticles formed by a temperature-induced phase transition for cancer therapy. J Control Release. 2010 ; 148: 344-350
28. Zhang X, Jackson JK, Burt HM. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm. 1996 ; 132: 195-206
29. Xing JZ, Zhu L, Jackson JA, et al. Dynamic monitoring of cytotoxicity on microelectronic sensors. Chem Res Toxicol. 2005 ; 18(2): 154-161
30. Mashat M, Chrystyn H, Clark BJ, et al. Development and validation of HPLC method for the determination of tobramycin in urine samples post-inhalation using pre-column derivatisation with fluorescein isothiocyanate. J Chromatogr B. 2008 ; 869: 59-66